{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:29:21Z","timestamp":1791599361651,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bioorg.2024.107759","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T22:46:08Z","timestamp":1724712368000},"page":"107759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors"],"prefix":"10.1016","volume":"152","author":[{"given":"Hend I.","family":"Abdelaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla R.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud F.","family":"Abo-Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Giovannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar H.","family":"Fahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar M.","family":"Abou-Seri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107759_b0005","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/s41396-019-0426-8","article-title":"A new widespread subclass of carbonic anhydrase in marine phytoplankton","volume":"13","author":"Jensen","year":"2019","journal-title":"ISME J."},{"key":"10.1016\/j.bioorg.2024.107759_b0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/metabo8020025","article-title":"Carbonic anhydrases and metabolism","volume":"8","author":"Supuran","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2024.107759_b0015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543776.2013.794788","article-title":"Antiglaucoma carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Masini","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2024.107759_b0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107759_b0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0030","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1517\/13543776.2013.790957","article-title":"Antiobesity carbonic anhydrase inhibitors: a literature and patent review","volume":"23","author":"Scozzafava","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2024.107759_b0035","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/cmdc.201600204","article-title":"Indazole, pyrazole, and oxazole derivatives targeting nitric oxide synthases and carbonic anhydrases","volume":"11","author":"Maccallini","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107759_b0040","doi-asserted-by":"crossref","unstructured":"E. Canepa, R. Parodi\u2010Rullan, R. Vazquez\u2010Torres, B. Gamallo\u2010Lana, R. Guzman\u2010Hernandez, N.L. Lemon, F. Angiulli, L. Debure, M.A. Ilies, L.J.A.s. \u00d8stergaard, Dementia. FDA\u2010approved carbonic anhydrase inhibitors reduce amyloid \u03b2 pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness, 2023.","DOI":"10.1101\/2022.07.19.500681"},{"key":"10.1016\/j.bioorg.2024.107759_b0045","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008\u20132013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2024.107759_b0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107759_b0055","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CRD.0b013e31822b4939","article-title":"Acetazolamide: a forgotten diuretic agent","volume":"19","author":"Kassamali","year":"2011","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.bioorg.2024.107759_b0060","first-page":"285","article-title":"Dichlorphenamide efficacy in the primary periodic paralyses","volume":"5","author":"Matthews","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.bioorg.2024.107759_b0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12325-020-01525-5","article-title":"Dorzolamide\/timolol fixed combination: learning from the past and looking toward the future","volume":"38","author":"Konstas","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bioorg.2024.107759_b0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/metabo8010019","article-title":"Carbonic anhydrases: role in pH control and cancer","volume":"8","author":"Mboge","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2024.107759_b0075","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2024.107759_b0080","series-title":"Semin. Cancer Biol.","first-page":"52","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","author":"Pastorek","year":"2015"},{"key":"10.1016\/j.bioorg.2024.107759_b0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"\u0160vastov\u00e1","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2024.107759_b0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ijc.31042","article-title":"Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer","volume":"142","author":"Bryant","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2024.107759_b0095","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/14756366.2012.736979","article-title":"Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro","volume":"28","author":"Gieling","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-378","article-title":"Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines","volume":"13","author":"Mokhtari","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2024.107759_b0105","first-page":"9299","article-title":"Combined treatment with acetazolamide and cisplatin enhances chemosensitivity in laryngeal carcinoma Hep-2 cells","volume":"15","author":"Gao","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bioorg.2024.107759_b0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/14756366.2018.1532419","article-title":"The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy","volume":"34","author":"Andreucci","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413405","article-title":"Carbonic anhydrase IX inhibitors as candidates for combination therapy of solid tumors","volume":"22","author":"Kalinin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107759_b0120","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9134","article-title":"Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors","volume":"7","author":"Faes","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2024.107759_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161040","article-title":"The sulfamate small molecule CAIX inhibitor S4 modulates doxorubicin efficacy","volume":"11","author":"van Kuijk","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.107759_b0130","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2024.107759_b0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejmech.2018.01.033","article-title":"Structural investigations on coumarins leading to chromeno [4, 3-c] pyrazol-4-ones and pyrano [4, 3-c] pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"146","author":"Bonardi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejmech.2017.11.061","article-title":"Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases","volume":"143","author":"De Luca","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0150","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acsmedchemlett.8b00170","article-title":"Targeting tumor associated carbonic anhydrases IX and XII: highly isozyme selective coumarin and psoralen inhibitors","volume":"9","author":"Melis","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107759_b0155","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/jm200983e","article-title":"Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors","volume":"54","author":"Touisni","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0160","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/jm901524f","article-title":"The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors","volume":"53","author":"Temperini","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0165","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bmc.2016.11.039","article-title":"Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity","volume":"25","author":"Bozdag","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105888","article-title":"Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity","volume":"126","author":"Ibrahim","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0175","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1021\/acsomega.8b02481","article-title":"Design, synthesis, antimicrobial evaluation, and molecular modeling studies of novel indolinedione\u2013coumarin molecular hybrids","volume":"4","author":"Bhagat","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2024.107759_b0180","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.bmc.2012.10.043","article-title":"Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer","volume":"21","author":"Winum","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0185","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.bmc.2016.04.052","article-title":"Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII","volume":"24","author":"Chandak","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112112","article-title":"Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells","volume":"190","author":"Petreni","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0195","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","article-title":"Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases","volume":"8","author":"Nocentini","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107759_b0200","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bioorg.2024.107759_b0205","doi-asserted-by":"crossref","first-page":"19043","DOI":"10.1039\/D1NJ02862F","article-title":"Novel coumarin\u2013pyrazoline hybrids: synthesis, cytotoxicity evaluation and molecular dynamics study","volume":"45","author":"Ragab","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0210","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100029","article-title":"Synthesis and biological evaluation of new coumarin derivatives as cytotoxic agents","volume":"354","author":"Ragab","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107759_b0215","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.bmc.2019.06.033","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids","volume":"27","author":"Singh","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104569","article-title":"Design, synthesis and in silico insights of new 7, 8-disubstituted-1, 3-dimethyl-1H-purine-2, 6 (3H, 7H)-dione derivatives with potent anticancer and multi-kinase inhibitory activities","volume":"107","author":"Mohamed","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0225","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1021\/jm0009540","article-title":"Synthesis and antitumor activities of novel pyrimidine derivatives of 2, 3-O, O-dibenzyl-6-deoxy-L-ascorbic acid and 4, 5-didehydro-5, 6-dideoxy-L-ascorbic acid","volume":"43","author":"Rai\u0107-Mali\u0107","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0230","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejmech.2014.03.018","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids","volume":"77","author":"Nepali","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0235","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1517\/17460440903341705","article-title":"Promise and challenges in drug discovery and development of hybrid anticancer drugs","volume":"4","author":"Gediya","year":"2009","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107759_b0240","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bioorg.2019.02.004","article-title":"Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors","volume":"86","author":"Thacker","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejmech.2014.06.027","article-title":"Synthesis and antitumor activity of pyrido [2, 3-d] pyrimidine and pyrido [2, 3-d][1, 2, 4] triazolo [4, 3-a] pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest","volume":"83","author":"Fares","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0250","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.bmc.2017.02.037","article-title":"Synthesis of bulky-tailed sulfonamides incorporating pyrido [2, 3-d][1, 2, 4] triazolo [4, 3-a] pyrimidin-1 (5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects","volume":"25","author":"Fares","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0255","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1016\/j.ejmech.2011.07.017","article-title":"Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives","volume":"46","author":"Secci","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0260","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/jhet.5570380428","article-title":"Studies with enaminones: synthesis of new coumarin-3-yl azoles, coumarin-3-yl azines, coumarin-3-yl azoloazines, coumarin-3-yl pyrone and coumarin-2-yl benzo [b] furans","volume":"38","author":"El-Taweel","year":"2001","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0265","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1016\/j.tetlet.2016.09.047","article-title":"Biginelli reaction: an overview","volume":"57","author":"Nagarajaiah","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2024.107759_b0270","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/14756366.2018.1474212","article-title":"Synthesis and in vivo anti-ulcer evaluation of some novel piperidine linked dihydropyrimidinone derivatives","volume":"33","author":"Ahmad Bhat","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0275","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3184\/174751916X14798125870610","article-title":"Synthesis and evaluation of antitumour activities of novel fused tri-and tetracyclic uracil derivatives","volume":"40","author":"ElKalyoubi","year":"2016","journal-title":"J. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107759_b0280","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1016\/j.bmc.2009.04.061","article-title":"6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors","volume":"17","author":"Crepaldi","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0285","article-title":"Reactions of nitriles under acidic conditions. part 9. synthesis of 6-amino-1-aryluracils, 6-amino-1-aryl-2-thiouracils and 6-amino-1, 3-diaryl-2-thiouracils under acidic conditions","volume":"27","author":"Shishoo","year":"1996","journal-title":"Chem. Inform."},{"key":"10.1016\/j.bioorg.2024.107759_b0290","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.tetlet.2011.05.021","article-title":"Improved synthesis of substituted pyrido [2, 3-d] pyrimidinediones","volume":"52","author":"Churchill","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2024.107759_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120380","article-title":"Hydrazonoyl chlorides possess promising antitumor properties","volume":"295","author":"El Gendy","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2024.107759_b0300","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase: I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0305","series-title":"Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval","author":"Teicher","year":"2013"},{"key":"10.1016\/j.bioorg.2024.107759_b0310","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430340203","article-title":"Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen","volume":"34","author":"Boyd","year":"1995","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2024.107759_b0315","first-page":"26","article-title":"Anthracycline derivatives and their anticancer activity","volume":"25","author":"Moiseeva","year":"2019","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2024.107759_b0320","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/2141-9248.126619","article-title":"An evaluation of hepatotoxicity in breast cancer patients receiving injection Doxorubicin","volume":"4","author":"Damodar","year":"2014","journal-title":"Ann. Med. Health Sci. Res."},{"key":"10.1016\/j.bioorg.2024.107759_b0325","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/03602532.2011.609174","article-title":"Possibilities to increase the effectiveness of doxorubicin in cancer cells killing","volume":"43","author":"Hanu\u0161ov\u00e1","year":"2011","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bioorg.2024.107759_b0330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2024.107759_b0335","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","article-title":"Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies","volume":"139","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113701","article-title":"Design, synthesis and biological activity evaluation of novel scopoletin-NO donor derivatives against MCF-7 human breast cancer in vitro and in vivo","volume":"224","author":"Yu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0345","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2024.107759_b0350","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2024.107759_b0355","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/14756366.2019.1697250","article-title":"Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation","volume":"35","author":"Abdelrahman","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0360","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.bmc.2017.03.063","article-title":"Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors","volume":"25","author":"Akocak","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0365","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/14756366.2017.1421181","article-title":"Novel [(3-indolylmethylene) hydrazono] indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation","volume":"33","author":"Eldehna","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107759_b0370","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824006643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824006643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T21:10:53Z","timestamp":1725657053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824006643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":74,"alternative-id":["S0045206824006643"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107759","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107759"}}